Repair-model research peptides are studied in wound-healing, tendon, muscle and gastrointestinal injury models, and the mechanisms proposed for them differ considerably from one compound to the next. BPC-157 has been examined largely in relation to nitric-oxide signalling and angiogenesis; TB-500, the synthetic fragment of thymosin beta-4, is studied for actin sequestration and cell migration; GHK-Cu is a copper-binding tripeptide with a separate literature centred on collagen and matrix remodelling.
That divergence matters when reading the evidence. Much of the BPC-157 literature originates from a single research group and remains preclinical, a limitation the published reviews state directly and one worth knowing before drawing conclusions from it. The compound pages in this category summarise what has been reported and cite the primary papers rather than asserting outcomes.
Every batch is independently tested before release, and both figures are published: purity from HPLC, and measured content against the labelled amount. Certificates are linked per lot to the vial in hand. All compounds here are supplied strictly for in-vitro laboratory research.